Literature DB >> 12967638

Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy.

Tetsuya Saito1, Jun Fukuzawa, Junzo Osaki, Hitoshi Sakuragi, Naoyuki Yao, Takashi Haneda, Takayuki Fujino, Nobutaka Wakamiya, Kenjiro Kikuchi, Naoyuki Hasebe.   

Abstract

Calcineurin and calcium/calmodulin-dependent protein kinase (CaMK) II have been suggested to be the signaling molecules in cardiac hypertrophy. It was not known, however, whether these mechanisms are involved in cardiac hypertrophy induced by pressure overload without the influences of blood-derived humoral factors, such as angiotensin II. To elucidate the roles of calcineurin and CaMK II in this situation, we examined the effects of calcineurin and CaMK II inhibitors on pressure overload-induced expression of c-fos, an immediate-early gene, and protein synthesis using heart perfusion model. The hearts isolated from Sprague-Dawley rats were perfused according to the Langendorff technique, and then subjected to the acute pressure overload by raising the perfusion pressure. The activation of calcineurin was evaluated by its complex formation with calmodulin and by its R-II phosphopeptide dephosphorylation. CaMK II activation was evaluated by its autophosphorylation. Expression of c-fos mRNA and rates of protein synthesis were measured by northern blot analysis and by 14C-phenylalanine incorporation, respectively. Acute pressure overload significantly increased calcineurin activity, CaMK II activity, c-fos expression and protein synthesis. Cyclosporin A and FK506, the calcineurin inhibitors, significantly inhibited the increases in both c-fos expression and protein synthesis. KN62, a CaMK II inhibitor, also significantly prevented the increase in protein synthesis, whereas it failed to affect the expression of c-fos. These results suggest that both calcineurin and CaMK II pathways are critical in the pressure overload-induced acceleration of protein synthesis, and that transcription of c-fos gene is regulated by calcineurin pathway but not by CaMK II pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967638     DOI: 10.1016/s0022-2828(03)00234-7

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  14 in total

Review 1.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

Review 2.  Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.

Authors:  Camilla Calvieri; Speranza Rubattu; Massimo Volpe
Journal:  J Mol Med (Berl)       Date:  2011-08-09       Impact factor: 4.599

3.  Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/β-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria.

Authors:  Lei Jiang; Lingling Xu; Yuxian Song; Jianzhong Li; Junhua Mao; Allan Zijian Zhao; Weichun He; Junwei Yang; Chunsun Dai
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

4.  Ca2+-calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel alpha(1C)-subunit gene (Cacna1c) by DREAM translocation.

Authors:  Jarkko J Ronkainen; Sandra L Hänninen; Topi Korhonen; Jussi T Koivumäki; Reka Skoumal; Sini Rautio; Veli-Pekka Ronkainen; Pasi Tavi
Journal:  J Physiol       Date:  2011-03-28       Impact factor: 5.182

5.  Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.

Authors:  Cui-cui Lu; Ying-qi Xu; Ji-chao Wu; Peng-zhou Hang; Yan Wang; Chen Wang; Jian-wei Wu; Jian-cui Qi; Yong Zhang; Zhi-min Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-28       Impact factor: 3.000

6.  Melatonin protects against myocardial hypertrophy induced by lipopolysaccharide.

Authors:  Qi Lu; Xin Yi; Xiang Cheng; Xiaohui Sun; Xiangjun Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-05       Impact factor: 2.416

7.  Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-15       Impact factor: 4.733

8.  Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure.

Authors:  Yanggan Wang; Samvit Tandan; Jun Cheng; Chunmei Yang; Lan Nguyen; Jessica Sugianto; Janet L Johnstone; Yuyang Sun; Joseph A Hill
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

9.  Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.

Authors:  Lin Zhao; Guangming Cheng; Runming Jin; Muhammad R Afzal; Anweshan Samanta; Yu-Ting Xuan; Magdy Girgis; Harold K Elias; Yanqing Zhu; Arash Davani; Yanjuan Yang; Xing Chen; Sheng Ye; Ou-Li Wang; Lei Chen; Jeryl Hauptman; Robert J Vincent; Buddhadeb Dawn
Journal:  Circ Res       Date:  2016-04-28       Impact factor: 17.367

10.  Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.

Authors:  Yingxia Bao; Ruifang Li; Jianmin Jiang; Birong Cai; Jie Gao; Kang Le; Fangyan Zhang; Shaorui Chen; Peiqing Liu
Journal:  Mol Cell Biochem       Date:  2008-07-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.